Why the study?
The study was conducted to validate the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria and the PRECISE-DAPT score in patients with STEMI undergoing PCI.
Do ARC-HBR criteria and PRECISE-DAPT score accurately predict 1-year bleeding events in STEMI patients undergoing PCI?
Do ARC-HBR criteria and PRECISE-DAPT score accurately predict 1-year bleeding events in STEMI patients undergoing PCI?
Both ARC-HBR criteria and PRECISE-DAPT score demonstrate high predictive ability for 1-year bleeding events in STEMI patients undergoing PCI, especially when excluding those with mechanical hemodynamic support devices.
Answers are grounded in this paper and cite their sources.
ARC-HBR and PRECISE-DAPT show comparable bleeding discrimination in STEMI PCI; observational data leave open impact on therapy decisions.
BACKGROUND: This observational study validated Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria and the Predicting Bleeding Complication in Patients Undergoing Stent Implantation and Subsequent Dual Antiplatelet Therapy (PRECISE-DAPT) score in patients with ST-elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention. METHODS AND RESULTS: Risk clusters of 939 STEMI patients with traceable 1-year outcomes were assessed according to ARC-HBR criteria and PRECISE-DAPT score. The diagnostic accuracy and first-year probability of bleeding events, defined as Bleeding Academic Research Consortium (BARC) 3 or 5, according to risk cluster were assessed. Of all patients, 42.9% and 46.8% were classified as HBR (ARC-HBR criteria) and at high risk (PRECISE-DAPT score), respectively, and bleeding events were observed in 13.7% and 16.2% of these patients. The C-statistic for ARC-HBR criteria and the PRECISEDAPT score was 0.60 and 0.69, respectively (P<0.01). Patients with mechanical hemodynamic support devices had high bleeding rates, even in the non-HBR group (22.6%), and excluding these patients improved the C-statistics, making them equivalent between the 2 models (0.72 vs. 0.74; P=0.53). Bleeding event probabilities (95% confidence intervals) were equivalent in high-risk patients in the 2 models (0.12 [0.09-0.16] vs. 0.12 [0.08-0.16]). CONCLUSIONS: After exclusion of patients with mechanical devices, who had high bleeding event rates regardless of risk cluster, both ARC-HBR criteria and the PRECISE-DAPT score had high predictive ability.
No takes yet. Share an insight, caveat, or question.
Fujii et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: